Synthetic Biology Market

Transparency Market Research
Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to Growing R&D Efforts
Published Date
08-April-2014
143 Page Report
Buy Now
Request Sample
Press Release
http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Breast Pumps Market
REPORT DESCRIPTION
Global Synthetic Biology Market to Expand at 32.60% CAGR till 2019 Thanks to
Growing R&D Efforts
The global synthetic biology market is projected to grow remarkably, says a report from Transparency Market Research
(TMR). This report is titled “Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019”. The research study on the global synthetic biology market offers a 360-degree view of the market.
According to this report, the global synthetic biology market will expand at a 32.60% CAGR during the forecast period
from 2013 to 2019. In 2012, the global synthetic biology market was worth US$1.8 bn and by 2019, the market is
expected to be worth US$13.4 bn. The global synthetic biology market is driven by the growing demand for improved
drugs and vaccines. Furthermore, advancement in molecular biology will also fuel the global synthetic biology market.
This trend is gaining traction in the market as the participation of government bodies and universities in research on
synthetic biology is rising. Furthermore, the demand for genetically modified crops (GMOs) due to the expanding global
population is also driving advancement in molecular biology.
By product type, the global synthetic biology market is divided into core products (chassis organisms, XNA, synthetic
cells, synthetic genes, and synthetic DNA) and enabling products (oligonucleotide synthesis and DNA synthesis). In 2012,
the synthetic biology market was dominated by the synthetic DNA segment due to the higher commercial availability of
this product as compared to other core products.
On the basis of technology, the global synthetic biology market is divided into bioinformatics, DNA sequencing, genome
engineering, and biological components and integrated systems. As genome engineering can be used for genetically
2
Transparency Market Research
Breast Pumps Market
modifying foods, gene therapy, and gene cloning, the application of genome engineering has grown, in turn driving the
global synthetic biology market.
Application-wise, the global synthetic biology market is segmented into agriculture, chemicals, healthcare, and others.
The largest market share in the global synthetic biology market is held by the healthcare sector, as there is high utilization
of synthetic biology techniques to make cheap vaccines and drugs. On the other hand, the agriculture application segment
of the global synthetic biology market is expected to experience the highest growth during the forecast period.
On the basis of geography, the global synthetic biology market is classified into Asia Pacific, Europe, North America, and
Rest of the World (RoW). Europe held the largest market share in the global synthetic biology market in 2012 and is
projected to grow consistently in the foreseeable future. The Europe synthetic biology market benefits from the efforts of
government and private firms towards the development of this field. Funding for synthetic biology research in Europe is
high. The start of the €70-bn Horizon 2020 program in Europe represents a pivotal moment for this regional synthetic
biology market.
Enquiry before Buying:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421
Some of the key market players of the global synthetic biology market include Agrivida, Inc., Biosearch Technologies,
Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporationand others. Market players are profiled in this report on the basis
of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure
sustainability and maximize profits, product portfolio and recent developments.
Browse Full Press Release @
http://www.transparencymarketresearch.com/synthetic-biology-market.html
TABLE OF CONTENT
3
Transparency Market Research
Breast Pumps Market
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million)
2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Drivers
3.2.1.1 Rising demand for improved drugs and vaccines
3.2.1.2 Advancement in molecular biology
3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology
research
3.2.1.4 Increasing demand of genetically modified crops due to rising population
3.3 Market Restraints
3.3.1 Ethical Issues
3.4 Market Opportunities
3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts
3.5 Porter’s Five Force Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
4
Transparency Market Research
Breast Pumps Market
Chapter 4 Global Synthetic Biology Market, by Products
4.1 Introduction
4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Core Products
4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2.2 Synthetic DNA
4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)
4.2.3 Synthetic Genes
4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)
4.2.4 Synthetic Cells
4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
4.2.5 XNA (Xeno Nucleic Acid)
4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million)
4.2.6 Chassis Organisms
4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)
4.3 Enabling Products
4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)
4.3.2 DNA Synthesis
4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)
4.3.3 Oligonucleotide Synthesis
4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Synthetic Biology Market, by Technologies
5.1 Introduction
5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)
5.2 Genome Engineering
5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.3 DNA Sequencing
5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.4 Bioinformatics
5
Transparency Market Research
Breast Pumps Market
5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.5 Biological Components and Integrated Systems
5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019
(USD Million)
Chapter 6 Global Synthetic Biology Market, by Applications
6.1 Introduction
6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)
6.2 Chemicals
6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million)
6.3 Healthcare
6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)
6.4 Agriculture
6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)
6.5 Others (Biosecurity, R&D, Energy and Environment)
6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Synthetic Biology Market, by Geography
7.1 Introduction
7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for Key Market Players
6
Transparency Market Research
Breast Pumps Market
8.1.1 Amyris, Inc.
8.1.2 DuPont, Inc.
8.1.3 Royal DSM
8.1.4 Evolva Holding
8.1.5 Life Technologies Corporation
8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
Chapter 9 Recommendations
9.1 Market Strategy for Success
9.1.1 Focus on investing in research and development activities
9.1.2 Strategic alliance, mergers and acquisitions
9.2 Barriers to be Considered
9.2.1 Ethical issues associated with synthetic biology products
Chapter 10 Company Profiles
10.1 Agrivida, Inc.
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 Amyris, Inc.
10.2.1 Company Profile
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Developments
10.3 Algenol Biofuels, Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
7
Transparency Market Research
Breast Pumps Market
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 ATG:biosynthetics GmbH
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Developments
10.5 Bayer AG
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 BIONEER CORPORATION
10.7.1 Company Overview
10.7.2 Product Portfolio
10.7.3 Business Strategies
10.7.4 Recent Developments
10.8 Biosearch Technologies, Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
8
Transparency Market Research
Breast Pumps Market
10.9 CBC Comprehensive Biomarker Center GmbH
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 Cobalt Technologies
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 DuPont, Inc.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 Evolva SA
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Exxon Mobil Corporation
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 Ginkgo Bioworks
9
Transparency Market Research
Breast Pumps Market
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments
10.15 GeneWorks Pty Ltd.
10.15.1 Company Overview
10.15.2 Financial Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.15.5 Recent Developments
10.16 Genomatica, Inc.
10.16.1 Company Overview
10.16.2 Financial Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.16.5 Recent Developments
10.17 GeneScript Corporation
10.17.1 Company Overview
10.17.2 Financial Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.17.5 Recent Developments
10.18 Gevo, Inc.
10.18.1 Company Overview
10.18.2 Financial Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.18.5 Recent Developments
10.19 Green Biologics Limited
10.19.1 Company Overview
10
Transparency Market Research
Breast Pumps Market
10.19.2 Financial Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.19.5 Recent Developments
10.20 New England Biolabs, Inc.
10.20.1 Company Overview
10.20.2 Financial Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
10.20.5 Recent Developments
10.21 OriGene Technologies, Inc.
10.21.1 Company Overview
10.21.2 Financial Overview
10.21.3 Product Portfolio
10.21.4 Business Strategies
10.21.5 Recent Developments
10.22 REG Life Sciences, LLC
10.22.1 Company Overview
10.22.2 Financial Overview
10.22.3 Product Portfolio
10.22.4 Business Strategies
10.22.5 Recent Developments
10.23 Royal DSM
10.23.1 Company Overview
10.23.2 Financial Overview
10.23.3 Product Portfolio
10.23.4 Business Strategies
10.23.5 Recent Developments
10.24 Thermo Fisher Scientific, Inc.
10.24.1 Company Overview
10.24.2 Financial Overview
11
Transparency Market Research
Breast Pumps Market
10.24.3 Product Portfolio
10.24.4 Business Strategies
10.24.5 Recent Developments
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and
consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical,
chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR
research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape,
detailed segmentation, key trends, and strategic recommendations.
Contact
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
12
Transparency Market Research

The global synthetic biology market will expand at a 32.60% CAGR during the forecast period from 2013 to 2019. In 2012, the global synthetic biology market was worth US$1.8 bn and by 2019, the market is expected to be worth US$13.4 bn. The global synthetic biology market is driven by the growing demand for improved drugs and vaccines.